Gene · 6370
Papers1,976
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 1,976
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gastrointestinal Involvement in Long COVID and Potential Pathogenic Mechanisms. | Middle East J Dig Dis | 2022 | 36619270 | PubTator, text mining | PubMed |
| Cytokine Pathways in Cardiac Dysfunction following Burn Injury and Changes in Genome Expression. | J Pers Med | 2022 | 36579591 | PubTator, text mining | PubMed |
| Analysis of differentially expressed long non-coding RNAs in LPS-induced human HMC3 microglial cells. | BMC Genomics | 2022 | 36575377 | PubTator, text mining | PubMed |
| Fecal level of butyric acid, a microbiome-derived metabolite, is increased in patients with severe carotid atherosclerosis. | Sci Rep | 2022 | 36572703 | PubTator, text mining | PubMed |
| The role of metabolism on regulatory T cell development and its impact in tumor and transplantation immunity. | Front Immunol | 2022 | 36569866 | PubTator, text mining | PubMed |
| CC Chemokine Receptor 4 (CCR4) as a Possible New Target for Therapy. | Int J Mol Sci | 2022 | 36555280 | PubTator, text mining | PubMed |
| Conventional Ameloblastoma. A Case Report with Microarray and Bioinformatic Analysis. | Diagnostics (Basel) | 2022 | 36553196 | PubTator, text mining | PubMed |
| Evaluation of Atypical Chemokine Receptor Expression in T Cell Subsets. | Cells | 2022 | 36552863 | PubTator, text mining | PubMed |
| Harnessing the Potential of Chimeric Antigen Receptor T-Cell Therapy for the Treatment of T-Cell Malignancies: A Dare or Double Dare? | Cells | 2022 | 36552738 | PubTator, text mining | PubMed |
| The Role of Circulating Tumor Cells in Ovarian Cancer Dissemination. | Cancers (Basel) | 2022 | 36551515 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Transcriptomics and Genetic Alterations Identifies Potential Mechanisms Underlying Anthracycline Therapy Resistance in Breast Cancer. | Biomolecules | 2022 | 36551262 | PubTator, text mining | PubMed |
| Human JAK1 gain of function causes dysregulated myelopoeisis and severe allergic inflammation. | JCI Insight | 2022 | 36546480 | PubTator, text mining | PubMed |
| Molecular signatures in the progression of COVID-19 severity. | Sci Rep | 2022 | 36543855 | PubTator, text mining | PubMed |
| Intranasal inoculation of IFN-λ resolves SARS-CoV-2 lung infection via the rapid reduction of viral burden and improvement of tissue damage. | Front Immunol | 2022 | 36524125 | PubTator, text mining | PubMed |
| Targeting macrophages: a novel treatment strategy in solid tumors. | J Transl Med | 2022 | 36510315 | PubTator, text mining | PubMed |
| In patients with primary Sjögren's syndrome innate-like MAIT cells display upregulated IL-7R, IFN-γ, and IL-21 expression and have increased proportions of CCR9 and CXCR5-expressing cells. | Front Immunol | 2022 | 36505431 | PubTator, text mining | PubMed |
| Role of intestinal flora in primary sclerosing cholangitis and its potential therapeutic value. | World J Gastroenterol | 2022 | 36504550 | PubTator, text mining | PubMed |
| Genetic Heterogeneity, Tumor Microenvironment and Immunotherapy in Triple-Negative Breast Cancer. | Int J Mol Sci | 2022 | 36499265 | PubTator, text mining | PubMed |
| CCL22 and CCL26 are potential biomarkers for predicting distant metastasis in thyroid carcinoma. | J Int Med Res | 2022 | 36495170 | PubTator, text mining | PubMed |
| Upregulated UBE4B expression correlates with poor prognosis and tumor immune infiltration in hepatocellular carcinoma. | Aging (Albany NY) | 2022 | 36470669 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6370/papers?page=20